Department of Urology
Sun Yat-sen University Cancer Center, Guangzhou
泌尿外科 · Urology
Established in 1999, this department focuses on the clinical treatment, research, and teaching of urological and male reproductive system tumors. The team operates across two campuses with 116 beds and provides multidisciplinary care for kidney, bladder, and prostate cancers. Minimally invasive techniques are central to practice, with laparoscopic surgery becoming routine since 2000 and robotic surgery introduced in 2016. The department reports that over 95% of early-stage kidney cancer patients undergoing nephron-sparing surgery achieved cure, and five-year survival for metastatic kidney cancer improved to 57% following multidisciplinary management.
What the department treats
- Multidisciplinary treatment for kidney, bladder, and prostate cancers
- Laparoscopic minimally invasive surgery
- Da Vinci robotic surgery for urological tumors
- Nephron-sparing surgery for early-stage kidney cancer
- Radical cystectomy with urinary diversion
- Retroperitoneal lymph node dissection
Key facts
- The department was established in 1999.
- There are 23 full-time doctors and 116 hospital beds across two campuses.
- Over 3,000 Da Vinci robotic surgeries were performed between January 2016 and December 2021.
As described by the hospital.
Team
29 doctors listed, including 6 chief physicians. Its chief physicians have 86 first- or senior-author papers on PubMed since 2016.
| Chief physician | Clinical focus | Key papers since 2016 |
|---|---|---|
| Prof. Zhiling Zhang 张志凌 · Professor | Kidney-sparing surgery for renal tumors (robotic, laparoscopic, open), comprehensive treatment of complex or large renal tumors, and surgical treatment of retroperitoneal tumors. | 25 |
| Dr. Kai Yao 尧凯 · Associate Professor | Diagnosis and treatment of urologic and male reproductive system tumors, including open, laparoscopic, and robot-assisted surgery. | 21 |
| Dr. Shengjie Guo 郭胜杰 | Minimally invasive surgery for adrenal tumors, kidney cancer, and complex retroperitoneal tumors. Performs laparoscopic, single-port, and robotic procedures, including nephron-sparing surgery, vena cava tumor thrombectomy, and treatment of retroperitoneal sarcomas. | 15 |
| Dr. Pei Dong 董培 | Surgical treatment of kidney cancer, benign kidney tumors, adrenal tumors, and retroperitoneal tumors. Expertise in minimally invasive (laparoscopic/robotic) nephron-sparing surgery, complex adrenal and retroperitoneal mass resection, and comprehensive management of advanced or metastatic kidney cancer. | 11 |
| Dr. Yonghong Li 李永红 | Prostate cancer surgery, comprehensive management, and benign prostatic hyperplasia treatment. Expertise includes prostate biopsy, robotic-assisted and open surgery, ablation, and managing elevated PSA levels. | 7 |
| Dr. Xiangdong Li 李向东 | Comprehensive diagnosis and treatment of urogenital tumors, with a focus on bladder, testicular, kidney, and prostate cancers. | 7 |
Associate chief physicians
- Dr. Yunlin Ye叶云林
- Dr. Lijuan Jiang蒋丽娟
- Dr. Dong Chen陈东
- Dr. Zhiming Wu吴志明
- Dr. Wensu Wei危文素
- Dr. Zhiyong Li李志勇
- Dr. Zhenhua Liu刘振华
We are an independent coordination service, not part of this hospital. Team data comes from public doctor-listing platforms; publication counts come from PubMed, matched by full name and affiliation, and doctors with very common names are checked by hand before their papers are shown. How we build this directory.
Not sure which specialist is right?
Send your records. We find a specialist in the right field to review your case and write a treatment plan with a cost estimate.
Get a specialist opinion